20.29

3.36% 0.66

After Hours: 20.86 0.57 +2.81%

Kiniksa Pharmaceuticals International Plc (KNSA)

Overview News Price History Option Chain Financials Discussions Forecast

Kiniksa Pharmaceuticals International Plc stock is traded at $20.29, with a volume of 1.28M. It is up +3.36% in the last 24 hours and up +1.35% over the past month. Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

Previous Close:

$19.63

Open:

$19.75

24h Volume:

1.28M

Relative Volume:

3.69

Market Cap:

$1.46B

Revenue:

$384.10M

Net Income/Loss:

$-9.07M

P/E Ratio:

-144.93

EPS:

-0.14

Net Cash Flow:

$11.10M

1W Performance:

+2.06%

1M Performance:

+1.35%

6M Performance:

-16.43%

1Y Performance:

+9.73%

1-Day Range:

$19.60

$20.73

1-Week Range:

$18.52

$20.73

52-Week Range:

$16.56

$28.15

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Company Profile

Name

Kiniksa Pharmaceuticals International Plc

Sector

Healthcare (1177)

Industry

Drug Manufacturers - Specialty & Generic (1)

Phone

(781) 431-9100

Address

23 OLD BOND STREET, FLOOR 3, LONDON

Employee

297

Twitter

@kiniksa

Next Earnings Date

2024-10-29

Latest SEC Filings

KNSA's Discussions on Twitter

Compare KNSA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
KNSA Kiniksa Pharmaceuticals International Plc	20.29	1.46B	384.10M	-9.07M	11.10M	-0.14
ZTS Zoetis Inc	174.12	78.56B	9.15B	2.43B	2.31B	5.32
TAK Takeda Pharmaceutical Co Adr	13.61	43.15B	30.25B	1.37B	5.08B	0.4257
HLN Haleon Plc Adr	9.51	43.00B	14.26B	1.55B	0	0.3383
TEVA Teva Pharmaceutical Industries Ltd Adr	17.29	19.59B	16.54B	-1.64B	749.00M	-1.45
NBIX Neurocrine Biosciences Inc	150.51	15.24B	2.24B	385.90M	440.10M	3.73

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-13-24	Initiated	Jefferies	Buy
May-03-24	Initiated	Wells Fargo	Overweight
Jun-29-20	Reiterated	BofA Securities	Buy
Apr-01-20	Initiated	BofA/Merrill	Buy
Mar-11-19	Initiated	Barclays	Overweight
Dec-12-18	Reiterated	Wedbush	Outperform
Jun-19-18	Initiated	JMP Securities	Mkt Outperform

View All

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Latest News

Feb 06, 2025

Is Kiniksa Pharmaceuticals International Plc (KNSA) a opportunity to investors? - US Post News

Feb 06, 2025

Feb 05, 2025

Keeping an Eye on Kiniksa Pharmaceuticals International Plc (KNSA) After Insider Trading Activity - Knox Daily

Feb 05, 2025

Feb 04, 2025

Stock Market Recap: Kiniksa Pharmaceuticals International Plc (KNSA) Concludes at 18.88, a -3.67 Surge/Decline - The Dwinnex

Feb 04, 2025

Jan 28, 2025

Exploring High Growth Tech Stocks in the United States - Simply Wall St

Jan 28, 2025

Jan 20, 2025

Kiniksa Pharmaceuticals Reports Strong 2024 Financial Results and Provides 2025 Revenue Guidance - Defense World

Jan 20, 2025

Jan 16, 2025

Kiniksa Pharmaceuticals COO Tessari Eben sells shares worth $255,413 - Investing.com India

Jan 16, 2025

Jan 14, 2025

Evolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy | DelveInsight - GlobeNewswire Inc.

Jan 14, 2025

Jan 13, 2025

Kiniksa Pharmaceuticals Reports Preliminary 2024 Net Product Revenue and Provides 2025 Net Product Revenue Guidance - The Manila Times

Jan 13, 2025

Kiniksa Pharmaceuticals Reports Preliminary 2024 Net - GlobeNewswire

Jan 13, 2025

Kiniksa's ARCALYST Soars 79% to $416M in 2024, Projects Strong 2025 Growth to $580M - StockTitan

Jan 13, 2025

Jan 06, 2025

Kiniksa Pharmaceuticals to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan

Jan 06, 2025

Kiniksa Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire

Jan 06, 2025

Dec 18, 2024

Kiniksa Pharmaceuticals COO Tessari Eben sells shares worth $470k - Investing.com

Dec 18, 2024

Dec 11, 2024

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Shares Acquired by Fmr LLC - Defense World

Dec 11, 2024

Kiniksa Pharmaceuticals CFO sells shares worth $593,997 By Investing.com - Investing.com Nigeria

Dec 11, 2024

Dec 10, 2024

Kiniksa Pharmaceuticals CFO sells shares worth $593,997 - Investing.com

Dec 10, 2024

Dec 05, 2024

Kiniksa Pharmaceuticals CFO sells shares worth $323,008 By Investing.com - Investing.com Canada

Dec 05, 2024

Kiniksa Pharmaceuticals CFO sells shares worth $323,008 - Investing.com India

Dec 05, 2024

KNSA (Kiniksa Pharmaceuticals International) Treasury Stock : $0.0 Mil (As of Sep. 2024) - GuruFocus.com

Dec 05, 2024

Dec 02, 2024

Kiniksa Pharmaceuticals officer sells $194k in stock By Investing.com - Investing.com Nigeria

Dec 02, 2024

Kiniksa Pharmaceuticals officer sells $194k in stock - Investing.com India

Dec 02, 2024

Nov 30, 2024

Kiniksa Pharmaceuticals International, plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 - Marketscreener.com

Nov 30, 2024

Nov 26, 2024

Kiniksa Pharmaceuticals to Present at 7th Annual Evercore ISI HealthCONx Conference - Marketscreener.com

Nov 26, 2024

Nov 24, 2024

Principal Financial Group Inc. Sells 14,100 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) - Defense World

Nov 24, 2024

Nov 20, 2024

Kiniksa Pharmaceuticals COO sells shares valued at $357,680 By Investing.com - Investing.com Nigeria

Nov 20, 2024

Kiniksa Pharmaceuticals COO sells shares valued at $357,680 - Investing.com India

Nov 20, 2024

Nov 15, 2024

HHLR Advisors, Ltd. Reduces Stake in Kiniksa Pharmaceuticals Int - GuruFocus.com

Nov 15, 2024

Nov 13, 2024

Is Kiniksa Pharmaceuticals (KNSA) Top Performing European Stock Heading into 2025? - Insider Monkey

Nov 13, 2024

Nov 12, 2024

Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference 2024 | KNSA Stock News - StockTitan

Nov 12, 2024

Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference - GlobeNewswire

Nov 12, 2024

10 Top Performing European Stocks Heading into 2025 - Insider Monkey

Nov 12, 2024

Nov 04, 2024